Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HIK
  • CUSIP:
Key Metrics:
  • Previous Close: $22.45
  • 50 Day Moving Average: $2059.57
  • 200 Day Moving Average: $2255.27
  • 52-Week Range: GBX 1,575 - GBX 2,703
  • Trailing P/E Ratio: 22.19
  • P/E Growth: 1.01
  • Market Cap: $4.10B
  • Outstanding Shares: 226,000,000
Additional Links:

Analyst Ratings

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: GBX 2,520.90

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
DateFirmActionRatingPrice TargetDetails
9/23/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
9/12/2016Jefferies GroupLower Price TargetBuyGBX 2,990 -> GBX 2,500View Rating Details
9/9/2016Barclays PLCReiterated RatingOverweightGBX 2,900View Rating Details
8/24/2016Numis Securities LtdReiterated RatingHoldGBX 2,660View Rating Details
8/12/2016Morgan StanleyLower Price TargetEqual weightGBX 2,700 -> GBX 2,500View Rating Details
8/4/2016Citigroup Inc.DowngradeNeutralGBX 2,600View Rating Details
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details
3/29/2016HSBCReiterated RatingBuyGBX 2,525View Rating Details
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details
3/10/2016AlphaValueReiterated RatingBuyGBX 2,554View Rating Details
9/15/2015Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
9/2/2015Shore CapitalUpgradeBuyView Rating Details
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings announcements for this company have been tracked by MarketBeat.com


Earnings Estimates for Hikma Pharmaceuticals Plc (LON:HIK)
Current Year EPS Consensus Estimate: $1.09 EPS


Dividend History for Hikma Pharmaceuticals Plc (LON:HIK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/11/2015GBX 0.210.64%4/16/20154/16/20155/21/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (LON:HIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/28/2016Said DarwazahInsiderBuy10,000GBX 2,085£208,500
9/27/2016Ali Al-HusryInsiderBuy50,000GBX 2,094£1,047,000
9/26/2016Said DarwazahInsiderBuy50,000GBX 2,078£1,039,000
9/23/2016Ali Al-HusryInsiderBuy50,000GBX 2,099£1,049,500
9/21/2016Ali Al-HusryInsiderBuy50,000GBX 2,138£1,069,000
9/16/2016Al-Husry,AliInsiderBuy50,000GBX 2,119£1,059,500
9/15/2016Darwazah,SaidInsiderBuy70,251GBX 2,122£1,490,726.22
9/8/2016Darwazah,MazenInsiderBuy150,000GBX 2,162£3,243,000
9/6/2016Darwazah,MazenInsiderBuy155,991GBX 2,194£3,422,442.54
8/31/2016Al-Husry,AliInsiderBuy140,000GBX 2,150£3,010,000
8/26/2016Darwazah,SaidInsiderBuy200,000GBX 2,160£4,320,000
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88
(Data available from 1/1/2013 forward)


Latest Headlines for Hikma Pharmaceuticals Plc (LON:HIK)
investing.com logoU.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.49% - Investing.com (LON:HIK)
www.investing.com - October 26 at 8:34 AM
News IconChecking Moving Average and RSI Levels on Hikma Pharmaceuticals PLC (HIK.L) - Hot Stock News (LON:HIK)
hotherald.com - October 25 at 5:27 PM
News IconAnalysts Consensus For Hikma Pharmaceuticals (LON:HIK) - NewsDen (LON:HIK)
newsden.net - October 24 at 10:43 AM
News IconStock Focus: Technical Levels in Review for Hikma Pharmaceuticals PLC (HIK.L) - Hot Stock News (LON:HIK)
hotherald.com - October 24 at 10:43 AM
investing.com logoUK stocks lower at close of trade; Investing.com United Kingdom 100 down 0.11% - Investing.com (LON:HIK)
www.investing.com - October 23 at 9:52 AM
News IconReady for a Breakout? Stock Update on Hikma Pharmaceuticals PLC (HIK.L) - Yankee Analysts (LON:HIK)
yankeeanalysts.com - October 20 at 10:55 AM
finance.yahoo.com logoPropeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy (LON:HIK)
finance.yahoo.com - October 20 at 10:54 AM
publicnow.com logoHikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform (LON:HIK)
www.publicnow.com - October 20 at 10:54 AM
uk.finance.yahoo.com logoDirectors are buying these high growth stocks – should you follow them? (LON:HIK)
uk.finance.yahoo.com - October 19 at 10:20 AM
News IconRating Sentiment Worth Watching: How Many Hikma ... - MoneyMakingArticles (LON:HIK)
www.mmahotstuff.com - October 18 at 10:30 AM
uk.finance.yahoo.com logoAre these the FTSE 100’s best contrarian bets? (LON:HIK)
uk.finance.yahoo.com - October 11 at 5:37 PM
News IconInhalation Anesthesia Market – Global Industry Analysis Report, Share, Size, Growth, Price Trends and Forecast, 2016 – 2024: Fractovia.org (LON:HIK)
www.abnewswire.com - October 5 at 5:22 PM
publicnow.com logoMeet the Management Date (LON:HIK)
www.publicnow.com - October 4 at 10:13 AM
publicnow.com logoMeet the Management Day (LON:HIK)
www.publicnow.com - October 4 at 10:13 AM
marketwatch.com logoFTSE 100 closes sharply higher as pound is hit by prospect of ‘hard Brexit’ (LON:HIK)
www.marketwatch.com - October 3 at 5:11 PM
News IconLONDON MARKETS: FTSE 100 Leaps As Pound Is Hit By Prospect Of 'hard Brexit' (LON:HIK)
uk.advfn.com - October 3 at 10:03 AM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : September 29, 2016 (LON:HIK)
www.capitalcube.com - September 29 at 10:31 AM
News IconGlobal Nerve Gas Auto-Injector Market Research Report 2016: MERIDIAN MEDICAL TECHNOLOGIES., SIGMA-ALDRICH CO. LLC., SOPHARMA AD (LON:HIK)
www.medgadget.com - September 23 at 5:05 PM
4-traders.com logoHikma Pharmaceuticals : Board appointment and succession (LON:HIK)
www.4-traders.com - September 20 at 10:34 AM
rttnews.com logoHikma Pharma Announces Changes To Board Composition (LON:HIK)
www.rttnews.com - September 20 at 10:34 AM
publicnow.com logoBoard appointment and succession (LON:HIK)
www.publicnow.com - September 20 at 10:34 AM
uk.finance.yahoo.com logoShould you buy GlaxoSmithKline plc after its change in CEO? (LON:HIK)
uk.finance.yahoo.com - September 20 at 10:34 AM
News IconHikma Pharmaceuticals Plc (HIK) Price Target Cut to GBX 2500 by Analysts at Jefferies Group - NewsDen (LON:HIK)
newsden.net - September 18 at 5:10 PM
4-traders.com logoDIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Acquires Shares (LON:HIK)
www.4-traders.com - September 15 at 5:47 PM
directorstalkinterviews.com logoHikma Pharmaceuticals Plc 17% Potential Upside Indicated by JP Morgan Cazenove - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - September 14 at 5:33 PM
trustnet.com logoBroker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC (LON:HIK)
www.trustnet.com - September 14 at 9:40 AM
News IconXL Group PLC (XL) Downgraded by Janney Montgomery Scott (LON:HIK)
magseriesusa.net - September 12 at 5:20 PM
morningstar.co.uk logoDIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Buys Shares (LON:HIK)
www.morningstar.co.uk - September 8 at 5:21 PM
publicnow.com logoHikma Ventures invests in Chrono Therapeutics for the development of next generation transdermal drug delivery technology (LON:HIK)
www.publicnow.com - September 8 at 9:21 AM
bloomberg.com logoU.K. Stocks Jump Most Since June, Reversing Three-Day Decline (LON:HIK)
washpost.bloomberg.com - September 2 at 5:23 PM
marketwatch.com logoFTSE 100 rallies as weak U.S. jobs data seen delaying rate hike (LON:HIK)
www.marketwatch.com - September 2 at 10:16 AM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : September 2, 2016 (LON:HIK)
www.capitalcube.com - September 2 at 10:16 AM
4-traders.com logoDIRECTOR DEALINGS: Hikma Non-Executive Director Buys Shares (LON:HIK)
www.4-traders.com - August 26 at 5:16 PM
News IconIs It The Right Time To Buy Hikma Pharmaceuticals Plc (LON:HIK) Shares? - Simply Wall St (LON:HIK)
simplywall.st - August 26 at 8:25 AM
fool.co.uk logoIs Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today's update? - Motley Fool UK (LON:HIK)
www.fool.co.uk - August 26 at 8:25 AM
marketwatch.com logoHikma profit falls 14%; sticks to revenue forecast (LON:HIK)
www.marketwatch.com - August 25 at 10:26 AM
bloomberg.com logoDrugmakers, Miners Send British Stocks Toward Three-Week Low (LON:HIK)
washpost.bloomberg.com - August 25 at 10:26 AM
4-traders.com logoHikma Pharmaceuticals' : H1 posts drop 38% YoY (LON:HIK)
www.4-traders.com - August 25 at 10:26 AM
money.aol.co.uk logoIs Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today's update? - AOL Money UK (LON:HIK)
money.aol.co.uk - August 24 at 8:32 AM
biz.yahoo.com logoHalf Year 2016 Hikma Pharmaceuticals PLC Earnings Release - Before Market Open (LON:HIK)
biz.yahoo.com - August 24 at 8:32 AM
feeds.reuters.com logoDrugmaker Hikma first-half core operating profit falls 14 pct (LON:HIK)
feeds.reuters.com - August 24 at 3:18 AM
proactiveinvestors.co.uk logoFTSE 100 up 27 points (LON:HIK)
www.proactiveinvestors.co.uk - August 23 at 5:36 PM
proactiveinvestors.co.uk logoFTSE 100 pushes higher as supermarkets rally (LON:HIK)
www.proactiveinvestors.co.uk - August 23 at 9:48 AM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : August 18, 2016 (LON:HIK)
www.capitalcube.com - August 19 at 8:21 AM
capitalcube.com logoHikma Pharmaceuticals Plc :HIK-GB: Earnings Analysis: For the six months ended December 31, 2015 : August 17, 2016 (LON:HIK)
www.capitalcube.com - August 17 at 8:30 AM
publicnow.com logoHikma signs exclusive licensing, distribution and supply agreement with Basilea Pharmaceutica International Ltd. for Cresemba® (LON:HIK)
www.publicnow.com - August 17 at 8:30 AM
publicnow.com logoHikma announces the launch of Levoleucovorin for Injection in the US (LON:HIK)
www.publicnow.com - August 16 at 5:37 PM
News IconUS and EU Requirements for Pre-Merger Notification of an Acquisition of a Minority Shareholding Interest (LON:HIK)
www.natlawreview.com - August 10 at 12:50 PM
ftsenews.co.uk logoBarclays Capital reiterated Hikma Pharmaceuticals PLC (LON:HIK) as 'Overweight' With 2900 PT - FTSE News (LON:HIK)
www.ftsenews.co.uk - August 9 at 8:23 AM
4-traders.com logoHikma Pharmaceuticals : *BARCLAYS RAISES HIKMA PHARMACEUTICAL PT TO 2900 PENCE - 'OVERWEIGHT' (LON:HIK)
www.4-traders.com - August 8 at 5:37 PM


Last Updated on 10/26/2016 by MarketBeat.com Staff